Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery

NCT ID: NCT00399568

Last Updated: 2016-10-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

331 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-11-30

Study Completion Date

2007-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be investigating the efficacy and safety administration of multiple doses of intravenous (IV) acetaminophen (IVAPAP) in the 48 hour period following Gynecologic Surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The research hypothesis is that IV Acetaminophen will provide greater reduction in pain intensity and greater pain relief for moderate and severe pain as compared to placebo in the 48 hours following surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain Hysterectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IV acetaminophen 1 g/100 mL solution

Group Type EXPERIMENTAL

IV Acetaminophen

Intervention Type DRUG

Intravenous acetaminophen 1 g/100 mL

IV Placebo 100 mL solution

Group Type PLACEBO_COMPARATOR

IV Placebo 100 mL solution

Intervention Type DRUG

IV Placebo 100 mL solution dosed at same frequency as IV Acetaminophen every 6 hours (q6h)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IV Acetaminophen

Intravenous acetaminophen 1 g/100 mL

Intervention Type DRUG

IV Placebo 100 mL solution

IV Placebo 100 mL solution dosed at same frequency as IV Acetaminophen every 6 hours (q6h)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

IV Acetaminophen (IV APAP) IV Placebo (non-active product)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Undergo gynecologic surgery using standard abdominal approach such as midline or Pfannenstiel incision
* 18-75 years of age
* Body Mass Index (BMI) between 19-45
* American Society of Anesthesiologists (ASA) risk class of I, II, III
* Not have received neuraxial (spinal or epidural) opioid analgesics prior to or during surgery
* Moderate to Severe pain at rest

Exclusion Criteria

* Requires any additional surgical procedures either related or unrelated to gynecologic surgery during same hospitalization
* Procedures involving only minimal incisions such as laparotomy, laparoscopy, supraumbilical or Maylard incisions
* Has know hypersensitivity to opioids, acetaminophen, or the excipients of IV acetaminophen
* Known history of alcohol or drug abuse or misuse
* Has impaired liver function Aspartate transaminase(AST), Alanine aminotransferase(ALT), bilirubin greater than or equal to 2 times upper limit of normal
* Has significant medical disease(s), or conditions that may contraindicate participation in the study
* Has participated in another clinical trial within 30 days of surgery
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mallinckrodt

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama (Anesthesiology)

Birmingham, Alabama, United States

Site Status

Helen Keller Hospital

Sheffield, Alabama, United States

Site Status

Arizona Research Center, Inc (JC Lincoln)

Phoenix, Arizona, United States

Site Status

Arizona Research Center, Inc. (Arrowhead)

Phoenix, Arizona, United States

Site Status

Precision Trials

Phoenix, Arizona, United States

Site Status

Arcadia Methodist Hospital

Arcadia, California, United States

Site Status

Glendale Adventist Medical Center

Glendale, California, United States

Site Status

Huntington Memorial Hospital

Pasadena, California, United States

Site Status

Accurate Clinical Trials, Inc.

San Clemente, California, United States

Site Status

Visions Clinical Research

Boynton Beach, Florida, United States

Site Status

G and G Research, Inc.

Ft. Pierce, Florida, United States

Site Status

Century Clinical Research, INC

Holly Hill, Florida, United States

Site Status

Nature Coast Clinical Research

Inverness, Florida, United States

Site Status

University of Miami School of Medicine Dept. of Anesthesiology

Miami, Florida, United States

Site Status

Treasure Coast Obstetrics and Gynecology

Vero Beach, Florida, United States

Site Status

William Beaumont Hospital

Royal Oak, Michigan, United States

Site Status

Cooper Anesthesia

Camden, New Jersey, United States

Site Status

St. Peters University Hospital, Anesthesiology

New Brunswick, New Jersey, United States

Site Status

Albany Medical College Dept. of Anesthesiology

Albany, New York, United States

Site Status

Weill Medical College

New York, New York, United States

Site Status

Stony Brook Anesthesiology Health Sciences Cente

Stony Brook, New York, United States

Site Status

Jacobi Medical Center (Albert Einstein College of Medicine)

The Bronx, New York, United States

Site Status

The Ohio State University Medical Center

Columbus, Ohio, United States

Site Status

Allegheny Pain Managment

Altoona, Pennsylvania, United States

Site Status

Thomas Jefferson University Dept. of Anesthesiology

Philadelphia, Pennsylvania, United States

Site Status

Memorial Herman/Memorial City Hospital

Houston, Texas, United States

Site Status

Texas Woman's Hospital

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CPI-APA-301

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Preoperative IV Versus Oral Acetaminophen
NCT03468920 COMPLETED PHASE4